Drug Discovery

Loading the player...

Live Cell Imaging Reveals 2 Microdomains of Beta1 Adrenoreceptor Signaling

Jop van Berlo interviews Alexander Froese, a participant in the Early Career Pre-Conference Session, "The Next Best Thing in Cardiovascular Research."

Science NewsView All Science News

The Expressed Genome in CVD and Stroke: Refinement, Diagnosis, and Prediction
07/31/2017 | "Omics" studies promise to deepen our understanding of cardiovascular diseases and stroke and improve our ability to diagnose, predict, a...
Rec on Design, Execution, and Reporting of Animal Atherosclerosis Studies
07/20/2017 | Animal studies are a foundation for defining mechanisms of atherosclerosis and potential drug targets in cardiovascular diseases.
Science News (BCVS)
07/10/2017 | Science News, presentations, and video interviews from AHA's Basic Cardiovascular Science 2017 Scientific Sessions in Portland, Oregon

ATVB | PVD 2018 Scientific Sessions

Arteriosclerosis, Thrombosis and Vascular Biology | Peripheral Vascular Disease 2018 Scientific Sessions
May 10-12, 2018
Hilton San Francisco Union Square
San Francisco, California
 

Learn about ATVB|PVD

Networking for Professionals

Related Councils

Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)

Steven R. Lentz, MD, PhD, FAHA

The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.

Steven R. Lentz, MD, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology

ATVB|PVD Scientific Sessions       Arteriosclerosis, Thrombosis, and Vascular Biology       ATVB Council Awards

Council on Clinical Cardiology (CLCD)

Randal J. Thomas, MD MS FAHA FACC MAACVPR

The purpose of the Council on Clinical Cardiology (CLCD) is to achieve the objectives of the American Heart Association (AHA) in the field of clinical cardiology, to promote excellence in clinical care and to foster the professional development and education of clinical cardiologists. Through council-sponsored symposia, panels and scientific conferences, members can access new developments in the field and interpret and promote clinical cardiology to professional and lay audiences.

Randal J. Thomas, MD, MS, FAHA, FACC, MAACVPR
Chair, Council on Clinical Cardiology

Scientific Sessions       Circulation       CLCD Council Awards

Council on Functional Genomics and Translational Biology (FGTB)

Svati Shah, MD, MS, MHS, FAHA

The mission of the American Heart Association (AHA) Council on Functional Genomics and Translational Biology (FGTB) is to advance discoveries from genetics, systems and translational biology and to facilitate their application in global cardiovascular health and disease.

Svati Shah, MD, MS, MHS, FAHA
Chair, Council on Functional Genomics and Translational Biology

Scientific Sessions       Circulation: Cardiovascular Genetics      FGTB Council Awards